Article by Jennifer Kerr of the AP on AOL News:
The study on nevirapine (viramune) was bungled and put hundreds of mothers 
and babies in Uganda at risk, according to Dr. Jonathan Fishbein of the NIH.  
Nevirapine is used in preventing mother to child transmission (MTCT) of 
hiv/aids.  Fishbein is being fired by the NIH and he believes he is being fired in 
retaliation for speaking out.  

http://aolsvc.news.aol.com/news/article.adp?id=20050104212309990001

A young woman in the USA, who was diagnosed with hiv but not sick,  died 
recently from drug toxicity-liver failure directly attributed to her therapy 
(nevirapine was part of the drugs she took).  She was given a c-section before 
death and her baby survived.  The mother was a part of an NIH research study.  I 
believe that the family is seeking legal redress.

For those of us that work in states or countries in which hiv/aids and MTCT 
transmission is of concern, I thought this information worth sharing.  
Valerie W. McClain, breastfeeding advocate

             ***********************************************

To temporarily stop your subscription: set lactnet nomail
To start it again: set lactnet mail (or digest)
To unsubscribe: unsubscribe lactnet
All commands go to [log in to unmask]

The LACTNET mailing list is powered by L-Soft's renowned
LISTSERV(R) list management software together with L-Soft's LSMTP(R)
mailer for lightning fast mail delivery. For more information, go to:
http://www.lsoft.com/LISTSERV-powered.html